Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)
CUSIP: 34962G109
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 20,563,488
- Total 13F shares
- 19,048,634
- Share change
- +189,799
- Total reported value
- $13,285,300
- Put/Call ratio
- 0%
- Price per share
- $0.70
- Number of holders
- 32
- Value change
- +$131,933
- Number of buys
- 8
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 34962G109?
CUSIP 34962G109 identifies FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 34962G109:
Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
18%
|
3,624,548
|
$2,978,292 | — | 31 Dec 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
16%
|
3,265,359
|
$2,683,145 | — | 31 Dec 2023 | |
| BVF INC/IL |
13F
|
Company |
15%
|
2,982,105
|
$2,450,396 | — | 31 Dec 2023 | |
| Cable Car Capital, LP |
13F
|
Company |
9.9%
|
2,031,987
|
$1,669,684 | — | 31 Dec 2023 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
8.9%
|
1,838,965
|
$1,511,078 | — | 31 Dec 2023 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
8.8%
|
1,810,455
|
$1,487,651 | — | 31 Dec 2023 | |
| BML Capital Management, LLC |
13F
|
Company |
8.6%
|
1,761,702
|
$1,447,591 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
665,230
|
$546,620 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
336,605
|
$276,656 | — | 31 Dec 2023 | |
| Hubert C. Chen |
3/4/5
|
President and Chief Scientific Officer |
—
mixed-class rows
|
183,405
mixed-class rows
|
$150,704 | — | 01 Jan 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.89%
|
182,324
|
$149,815 | — | 31 Dec 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.63%
|
129,800
|
$107,000 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.2%
|
41,664
|
$34,235 | — | 31 Dec 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.2%
|
40,964
|
$33,660 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
26,911
|
$22,113 | — | 31 Dec 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.12%
|
24,791
|
$20,371 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
20,740
|
$17,042 | — | 31 Dec 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.08%
|
15,827
|
$13,005 | — | 31 Dec 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.08%
|
15,432
|
$12,680 | — | 31 Dec 2023 | |
| Aries Wealth Management |
13F
|
Company |
0.06%
|
13,000
|
$10,682 | — | 31 Dec 2023 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.05%
|
10,745
|
$8,703 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
8,617
|
$7,081 | — | 31 Dec 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
5,781
|
$4,752 | — | 31 Dec 2023 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.02%
|
3,987
|
$3,000 | — | 31 Dec 2023 | |
| LM Advisors LLC |
13F
|
Company |
0.01%
|
2,531
|
$2,078 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
994
|
$817 | — | 31 Dec 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
1,080
|
$712 | — | 31 Dec 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0%
|
453
|
$372 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
248
|
$204 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
146
|
$120 | — | 31 Dec 2023 | |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA |
13F
|
Company |
0%
|
193
|
$118 | — | 31 Dec 2023 | |
| REAP Financial Group, LLC |
13F
|
Company |
0%
|
97
|
$80 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
21
|
$17 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
17
|
$14 | — | 31 Dec 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
3
|
$2 | — | 31 Dec 2023 | |
| Patricia S. Walker |
3/4/5
|
Director |
—
class O/S missing
|
25,000
|
— | — | 01 Jun 2022 |
Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) as of Q1 2024
As of 31 Mar 2024,
Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,048,634 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, PERCEPTIVE ADVISORS LLC, BVF INC/IL, Cable Car Capital LLC, FRED ALGER MANAGEMENT, LLC, FARALLON CAPITAL MANAGEMENT LLC, BML Capital Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock Inc..
This page lists
32
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
34
Q1 2024 holders
32
Holder diff
-2
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.